Islet‐expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation
Open Access
- 26 July 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 40 (10) , 2914-2924
Abstract
Although islet transplantation is an effective treatment for Type 1 diabetes, primary engraftment failure contributes to suboptimal outcomes. We tested the hypothesis that islet isolation and transplantation activate innate immunity through TLR expressed on islets. Murine islets constitutively express TLR2 and TLR4, and TLR activation with peptidoglycan or LPS upregulates islet production of cytokines and chemokines. Following transplantation into streptozotocin‐induced diabetic, syngeneic mice, islets exposed to LPS or peptidoglycan had primary graft failure with intra‐ and peri‐islet mononuclear cell inflammation. The use of knockout mice showed that recipient CD8+ T cells caused engraftment failure and did so in the absence of islet‐derived DC. To mimic physiological islet injury, islets were transplanted with exocrine debris. Transplantation of TLR2/4−/− islets reduced proinflammatory cytokine production and improved islet survival. Stressed islets released the alarmin high‐mobility group box protein 1 (HMGB1) and recombinant HMGB1 (rHMGB1) induced NFkB activation. NFkB activation was prevented in the absence of both TLR2 and TLR4. rHMGB1 pretreatment also prevented primary engraftment through a TLR2/4‐dependent pathway. Our results show that islet graft failure can be initiated by TLR2 and TLR4 signaling and suggest that HMGB1 is one likely early mediator. Subsequent downstream signaling results in intra‐islet inflammation followed by T‐cell‐mediated graft destruction.Keywords
This publication has 36 references indexed in Scilit:
- High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in miceJournal of Clinical Investigation, 2010
- Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survivalImmunology Letters, 2010
- Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantationProceedings of the National Academy of Sciences, 2009
- The Multiple Facets of Toll-Like Receptors in Transplantation BiologyTransplantation, 2008
- A calculated response: control of inflammation by the innate immune systemJournal of Clinical Investigation, 2008
- HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signalingJournal of Experimental Medicine, 2007
- Interleukin-1 Stimulates β-Cell Necrosis and Release of the Immunological Adjuvant HMGB1PLOS Medicine, 2005
- Role of Donor-Derived Monocyte Chemoattractant Protein-1 in Murine Islet TransplantationJournal of the American Society of Nephrology, 2005
- Differential Expression of Chemokines and Chemokine Receptors in Murine Islet AllograftsJournal of the American Society of Nephrology, 2004
- Adenovirus Transduction Induces Expression of Multiple Chemokines and Chemokine Receptors in Murine β Cells and Pancreatic IsletsAmerican Journal of Transplantation, 2003